Portola Pharmaceuticals (NASDAQ:PTLA)
Historical Stock Chart
2 Months : From Dec 2019 to Feb 2020
The Law Offices of Frank R. Cruz announces an investigation on behalf of Portola Pharmaceuticals, Inc. (“Portola” or the “Company”) (NASDAQ: PTLA) investors concerning the Company and its officers’ possible violations of federal securities laws.
If you are a shareholder who suffered a loss, click here to participate.
On January 9, 2020, Portola announced that it only expected $28 million revenue for Andexxa in fourth quarter 2019, well below expectations of revenue between $39 million and $41 million.
On this news, the Company’s share price fell as much as $10.55, or nearly 43%, during intraday trading on January 10, 2020, thereby injuring investors.
Follow us for updates on Twitter: twitter.com/FRC_LAW.
If you purchased Portola securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to firstname.lastname@example.org, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200110005580/en/
The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007